| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |